Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 2Phase 1/2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 18Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 10Lymphoma 10Burkitt Lymphoma 8Graft vs Host Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Non-Hodgkin 5Leukemia, Neutrophilic, Chronic 5Congenital Abnormalities 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Neoplasms, Plasma Cell 3

Interventions

Rituximab 17Cyclophosphamide 9fludarabine phosphate 8Peripheral Blood Stem Cell Transplantation 7Lenalidomide 6Filgrastim 6Mycophenolic Acid 5ibritumomab tiuxetan 4Whole-Body Irradiation 4Indium 4Everolimus 4Bortezomib 4romidepsin 3Sirolimus 3Etoposide 3Cyclosporine 3temsirolimus 2bazlitoran 2alvocidib 2Tacrolimus 2Radiotherapy 2Prednisone 2Methotrexate 2In Situ Hybridization, Fluorescence 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Busulfan 2Biopsy 2Antilymphocyte Serum 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Waldenstrom Macroglobulinemia × Methotrexate × Clear all
NCT00281983 2017-07-24

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

German CLL Study Group

Phase 1/2 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00448357 2017-07-17

LCCC0510

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Completed
54 enrolled 17 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡